Late line monoclonal antibody therapy for the treatment of metastatic colorectal cancer appears to be effective even in the presence of mutations in a proto-oncogene. Karl Landsteiner University of Health Sciences is an important
WeiterlesenCombination Therapy for Colorectal Cancer Shows Benefit Despite RAS Gene Mutations
